Skip to main navigation
Toggle navigation
Facebook
Instagram
Twitter
Linkedin
Email
Company
Company Submenu
Company
Team
Management and Board
Scientific Advisory Board
Our Work
Our Pipeline
Our Pipeline Submenu
Our Pipeline
ACG-801 (Farber Disease)
ACG-701 (Melioidosis)
ACG-701 (Cystic Fibrosis)
Patient Info
Patient Info Submenu
Patient Info
Farber Disease
Melioidosis
Cystic Fibrosis
Contact Us
Investors
Investors & Media
Special Meeting of Stockholders
Press Releases
Investor Events
Corporate Governance
Stock Information
SEC Filings
Investor Information
Contact Us
Please direct all questions regarding Aceragen to:
Aceragen, Inc.
15 TW Alexander Drive
Durham, NC 27709
info@aceragen.com
Print Page
RSS Feeds
Email Alerts
Committee Composition
Highlights
Management & Directors
Committee Composition
Guidelines
Conduct
Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Director Name
Audit Committee
Compensation Committee
Nominating & Corporate Governance Committee
Cristina Csimma, Pharm. D., M.H.P.
member of
Compensation Committee
chairperson of
Nominating & Corporate Governance Committee
Michael Dougherty
chairperson of
Audit Committee
member of
Nominating & Corporate Governance Committee
Maxine Gowen, PhD
member of
Audit Committee
chairperson of
Compensation Committee
Ron Wooten
member of
Audit Committee
Legend
= Chairperson
= Member
You are Leaving this Site
You are leaving investors.aceragen.com, a website provided [on behalf of /by] Aceragen.